AKT 3 COMBIPACK is a combination of Ethambutol, Isoniazid and Rifampicin which belongs to the group of medicines called Antituberculosis agents respectively. It is used for the initial management of tuberculosis. Tuberculosis (TB) is a bacterial infection which spreads through inhaling tiny droplets from the coughs or sneezes of an infected person. Symptoms such as persistent cough with sputum and blood, weight loss, night sweats, high temperature, tiredness and fatigue, loss of appetite and swelling in the neck.
Your doctor will perform some regular blood tests such as liver function test, visual acuity, uric acid level to monitor any changes in your body. Avoid consumption of alcohol while taking this medicine, as it may cause liver damage. AKT 3 COMBIPACK is not recommended in patients with acute liver disease, drug-induced liver disease, inflammation of the optic nerve (optic neuritis) and body weight of less than 20 kg. AKT 3 COMBIPACK should be used with caution in patients with hepatitis and kidney disease, suffer from tingling in the hands and feet (peripheral neuropathy), HIV infection, hypersensitive to ethionamide or niacin (nicotinic acid), epilepsy or a history of psychiatric disease and diabetes or porphyria.
AKT 3 COMBIPACK should be used with caution in pregnant and breastfeeding women. Contact your doctor before taking AKT 3 COMBIPACK. The most common side effects of taking AKT 3 COMBIPACK are peripheral neuropathy (sensations of tingling, pricking, or numbness of the skin, especially in the feet and hands), increased liver enzymes & uric acid levels in blood, flushing, reddish discoloration of body fluids such as urine, sputum, tears, saliva and sweat, diarrhoea, abdominal pain, loss of appetite, nausea, and vomiting or skin reactions. Consult your physician if you experience any of the above side effects worsen.
No content available
